Fulvestrant
Monthly injection that blocks and degrades the oestrogen receptor.
- Starts working
- Depends on the cancer and regimen
- Half-life
- About 40 days
- In use since
- —
- Pregnancy
- Usually avoided
Overview
Fulvestrant is a selective oestrogen receptor degrader given as two intramuscular injections on day 1 and then monthly. It is used for hormone-positive advanced breast cancer, alone or with palbociclib, ribociclib or abemaciclib.
Conditions it's used for
How it works
Blocks oestrogen from stimulating breast cancer cells.
Fulvestrant belongs to the Selective oestrogen receptor degraders. How Selective oestrogen receptor degraders work: block the oestrogen receptor and mark it for destruction.
Uses
- Hormone-receptor-positive advanced breast cancer
Available as: intramuscular injection.
Typical dose
- Adults
- Dosed by your cancer team according to the treatment protocol.
- Good to know
- Doses depend on body size, blood counts and the regimen.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Injection site pain
- Hot flushes
- Nausea
- Tiredness
- Joint pain
Serious — get medical help
Uncommon, but need prompt attention
- Liver enzyme rise
- Allergic reaction
- Bruising and bleeding at injection site
Warnings
- Use caution on anticoagulants because of injection bleeding
Who should avoid it
- Pregnancy
- Severe liver impairment
Interactions
- Anticoagulants — injection site bleeding
Using it safely
- Alcohol
- Usually no problem in moderation. No specific interaction.
- Food and drink
- Not applicable.
- If you miss a dose
- Contact your clinic.
- Stopping it
- Only on advice of your cancer team.
- Driving
- Tiredness is possible.
- Tests and checks
- Liver tests; Bone density
- If too much is taken
- Not expected to be harmful.
- Storage
- Refrigerate.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Usually avoided
Avoid.
Breastfeeding
Usually avoided
Avoid.
Special groups
- Kidney disease
- Dose may need adjusting; your team will advise.
- Liver disease
- Dose may need adjusting; your team will advise.
- Older adults
- Older adults may be more sensitive to side effects.
Brand names
- United States
- Faslodex
- United Kingdom
- Faslodex
- India
- Faslodex, Fulvestrant (generic)
- Australia
- Faslodex
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Fulvestrant?
Yes — Fulvestrant is prescription-only in most countries.
Can I take Fulvestrant during pregnancy?
Usually avoided. Avoid. Always check with a doctor or midwife.
How quickly does Fulvestrant work?
Depends on the cancer and regimen.
Related medicines
Anastrozole
Aromatase inhibitor for breast cancer treatment and prevention.
RxWHOAromatase inhibitorsTamoxifen
Hormone therapy that has saved hundreds of thousands from breast cancer.
RxWHOSelective oestrogen receptor modulatorsPalbociclib
CDK4/6 inhibitor for hormone-positive breast cancer.
RxWHOCDK4/6 inhibitorsRibociclib
CDK4/6 inhibitor with QT effects, for hormone-positive breast cancer.
RxWHOCDK4/6 inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — L02BA03
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.